Results 51 to 60 of about 84,996 (200)

RSV specific IgG and isotype IgG antibody responses after prime immunization with FI-RSV-via IM or MN patch.

open access: yes, 2018
RSV specific IgG, isotype IgG1 and Ig2a serum antibodies were determined at 2 weeks after prime immunization (n = 5) by ELISA using FI-RSV as a coating antigen. (A) IgG, (B) IgG1 and (C) IgG2a levels.
Barney Graham (5900309)   +10 more
core   +1 more source

Assessing parenting capacity to identify RSV symptoms and the impact on their children’s health: A brief report

open access: yesAmerican Journal of Experimental and Clinical Research, 2023
Respiratory syncytial virus (RSV) is a viral infectious disease that has detrimentally affected the quality of life in children younger than 2 years of age since it was discovered in 1956. It is the major cause of lower respiratory tract illness in young
José Andres Isla Gomez   +1 more
doaj  

RSV Replication, Transmission, and Disease Are Influenced by the RSV G Protein

open access: yesViruses, 2022
It is important to understand the features affecting virus replication, fitness, and transmissibility as they contribute to the outcome of infection and affect disease intervention approaches. Respiratory syncytial virus (RSV) is a major contributor to respiratory disease, particularly in the infant and elderly populations.
Harrison C. Bergeron, Ralph A. Tripp
openaire   +3 more sources

Cochlear implant

open access: yesJKS (Jurnal Kedokteran Syiah Kuala), 2008
Abstrak.   Cochlear implant (Cl)  merupakan   alat  elektronik    yang  sebagiannya   ditanam    melalui    prosedur pembedahan    dan   sebagian  lagi  berada  di   luar tubuh,     memiliki    fungsi  memperbaiki   proses  rnendengar dan komunikasi ...
Teuku Husni T.R
doaj  

Respiratory Syncytial Virus Prevention through Monoclonal Antibodies: A Cross-Sectional Study on Knowledge, Attitudes, and Practices of Italian Pediatricians

open access: yesPediatric Reports, 2023
Respiratory Syncytial Virus (RSV) is a leading cause of morbidity and hospitalization in all infants. Many RSV vaccines and monoclonal antibodies (mAb) are currently under development to protect all infants, but to date preventive options are available ...
Matteo Riccò   +4 more
doaj   +1 more source

Impact of COVID-19 pandemic on the etiology and severity of respiratory viral infections in children

open access: yesВопросы вирусологии
Objective. To analyze the age-related characteristics of the contribution of influenza viruses, RSV, SARS-CoV-2, other pathogens to the development of severe acute respiratory infections (SARI) in children with an assessment of the disease severity ...
Anna А. Sominina   +20 more
doaj   +1 more source

A phase 1, randomized, placebo-controlled study to evaluate the safety and immunogenicity of an mRNA-based RSV prefusion F protein vaccine in healthy younger and older adults

open access: yesHuman Vaccines & Immunotherapeutics, 2021
Respiratory Syncytial Virus (RSV) causes lower respiratory tract infections that can be severe and sometimes fatal. The risk for severe RSV infection is highest in infants and older adults.
Antonios O. Aliprantis   +17 more
doaj   +1 more source

RSV-induced innate immune responses.

open access: yes, 2019
Different families of PRRs can induce innate immune responses after activation by RSV-derived PAMPs. Firstly, TLR-2, -3, -4, -6, and -7 (marked in green) are involved in the production of cytokines and chemokines upon RSV infection.
Bert Schepens (9498)   +2 more
core   +1 more source

Incidence and severity of respiratory syncytial virus pneumonia in rural Kenyan children identified through hospital surveillance [PDF]

open access: yes, 2009
Background.Although necessary for developing a rationale for vaccination, the burden of severe respiratory syncytial virus (RSV) disease in children in resource‐poor settings remains poorly defined.
Medley, GF   +23 more
core   +1 more source

Stability of expression of RSV F protein by rHPIV3-RSV-F vectors evaluated by a double-staining immunofluorescence plaque assay.

open access: yes, 2020
Vero cells were inoculated with 10-fold serial dilutions of the P4 stock of F-H3TMCT/N-P obtained from terminal dilution from transfection #1 and P2 stocks of F/preN, F-H3TMCT/preN, and F/N-P from transfection #2 (see Results).
Sonja Surman (185609)   +8 more
core   +1 more source

Home - About - Disclaimer - Privacy